Overview

Etoricoxib in the Treatment of Osteoarthritis (MK-0663-007)

Status:
Completed
Trial end date:
2002-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of etoricoxib in the treatment of osteoarthritis of the knee.
Phase:
Phase 2
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Diclofenac
Etoricoxib